Description

Benzothiazole, 2-(3,3-Dimethyloxiranyl)-, (+)- (9Ci) is a high-purity, optically active heterocyclic compound featuring a benzothiazole core fused with a dimethyloxirane (epoxide) moiety. This specific stereochemistry and functional group combination make it a valuable chiral building block and intermediate in advanced organic synthesis. It is primarily sought after by research and development chemists in the pharmaceutical and agrochemical industries. The compound is used to construct complex molecular architectures where precise stereocontrol is critical for biological activity.

Application

• Pharmaceutical Intermediate: Serves as a key chiral synthon in the research and development of new active pharmaceutical ingredients (APIs), particularly for central nervous system (CNS) and anti-infective drugs.
• Agrochemical Synthesis: Used in the development of novel herbicides, fungicides, and insecticides, where the benzothiazole moiety can contribute to specific biological targeting.
• Ligand and Catalyst Development: Acts as a precursor for creating specialized ligands used in asymmetric catalysis and metal-organic frameworks (MOFs).
• Material Science Research: Investigated as a monomer or additive for producing polymers with unique optical or electronic properties.
• Organic Synthesis Building Block: Utilized in academic and industrial R&D for constructing complex heterocyclic systems via ring-opening reactions of the epoxide group.

Basic Information

Product Name	Benzothiazole, 2-(3,3-Dimethyloxiranyl)-, (+)- (9Ci)
CAS No.	207744-90-9
Molecular Formula	C11H11NOS
Molecular Weight	205.27 g/mol
Synonyms	(+)-2-(3,3-Dimethyloxiranyl)benzothiazole; (R)-2-(3,3-Dimethyloxiranyl)benzothiazole; 2-[(2R)-3,3-Dimethyloxiran-2-yl]-1,3-benzothiazole; 2-(3,3-Dimethyl-2-oxiranyl)benzothiazole, (+)-; Benzothiazole, 2-(3,3-dimethyl-2-oxiranyl)-, (2R)-; Light-sensitive benzothiazole derivative
EINECS	Contact for details

Quality Control

Our Benzothiazole, 2-(3,3-Dimethyloxiranyl)-, (+)- (9Ci) is produced under strict quality management systems. Each batch undergoes comprehensive analytical testing, including chiral purity analysis by HPLC, to ensure identity, potency, and consistency. A detailed Certificate of Analysis (COA) providing batch-specific results for purity, enantiomeric excess, and related substances is supplied with every shipment. We adhere to cGMP guidelines for the production of advanced pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated place at controlled room temperature (15-25°C). Keep away from heat, sparks, and open flame. The compound is light-sensitive (store away from light).

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Enantiomeric Excess (Chiral HPLC)	≥ 99.0%
Melting Point	Contact for details
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.